COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing

Bone

Volumn 43, Issue 6, 2008, Pages 1075-1083

  Xie, Chao ^a   Ming, Xue ^a   Wang, Qun ^a   Schwarz, Edward M ^a   Guldberg, Robert E ^b   O'Keefe, Regis J ^a   Zhang, Xinping ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bone graft transplantation; Bone repair; Cyclooxygenase 2 (COX 2); Periosteal progenitors; Periosteum

Indexed keywords

CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE REMODELING; CARTILAGE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CORTICAL BONE; ENZYME INDUCTION; FEMUR; FRACTURE HEALING; HISTOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PERIOSTEUM; STEM CELL; WILD TYPE;

ANIMALS; BASE SEQUENCE; BONE AND BONES; CYCLOOXYGENASE 2; DNA PRIMERS; FRACTURE HEALING; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; STEM CELLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57049122815     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.08.109     Document Type: Article

References (39)

1. Allen M.R., Hock J.M., and Burr D.B. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 35 (2004) 1003-1012
2. Altman R.D., Latta L.L., Keer R., Renfree K., Hornicek F.J., and Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J. Orthop. Trauma 9 (1995) 392-400
3. Barnes G.L., Kostenuik P.J., Gerstenfeld L.C., and Einhorn T.A. Growth factor regulation of fracture repair. J. Bone Miner. Res. 14 (1999) 1805-1815
4. Clark J.G., Kostal K.M., and Marino B.A. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J. Biol. Chem. 257 (1982) 8098-8105
5. Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B., et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378 (1995) 406-409
6. Duvall C.L., Robert Taylor W., Weiss D., and Guldberg R.E. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H302-H310
7. Duvall C.L., Taylor W.R., Weiss D., Wojtowicz A.M., and Guldberg R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J. Bone Miner. Res. 22 (2007) 286-297
8. Frost H.M. The biology of fracture healing. An overview for clinicians. Part I. Clin. Orthop. Relat. Res. 248 (1989) 283-293
9. Frost H.M. The biology of fracture healing. An overview for clinicians. Part II. Clin. Orthop. Relat. Res. 248 (1989) 294-309
10. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell Biochem. 88 (2003) 873-884
11. Gerstenfeld L.C., Thiede M., Seibert K., Mielke C., Phippard D., Svagr B., et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 21 (2003) 670-675
12. Giannoudis P.V., MacDonald D.A., Matthews S.J., Smith R.M., Furlong A.J., and De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J. Bone Joint Surg. Br. 82 (2000) 655-658
13. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999) 698-701
14. Goodman S.B. Use of COX-2 specific inhibitors in operative and nonoperative management of patients with arthritis. Orthopedics 23 (2000) S765-S768
15. Herschman H.R. Prostaglandin synthase 2. Biochem. Biophys. Acta 1229 (1996) 125-140
16. Ho M.L., Chang J.K., Chuang L.Y., Hsu H.K., and Wang G.J. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem. Pharmacol. 58 (1999) 983-990
17. Hodges R.J., Jenkins R.G., Wheeler-Jones C.P., Copeman D.M., Bottoms S.E., Bellingan G.J., et al. Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am. J. Pathol. 165 (2004) 1663-1676
18. Ito H., Koefoed M., Tiyapatanaputi P., Gromov K., Goater J.J., Carmouche J., et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat. Med. 11 (2005) 291-297
19. Kapoor M., Shaw O., and Appleton I. Possible anti-inflammatory role of COX-2-derived prostaglandins: implications for inflammation research. Curr. Opin. Investig. Drugs 6 (2005) 461-466
20. Langenbach R., Loftin C., Lee C., and Tiano H. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58 (1999) 1237-1246
21. Le A.X., Miclau T., Hu D., and Helms J.A. Molecular aspects of healing in stabilized and non-stabilized fractures. J. Orthop. Res. 19 (2001) 78-84
22. Mizuno H., Sakamoto C., Matsuda K., Wada K., Uchida T., Noguchi H., et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112 (1997) 387-397
23. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83 (1995) 473-482
24. Mungo D.V., Zhang X., O'Keefe R.J., Rosier R.N., Puzas J.E., and Schwarz E.M. COX-1 and COX-2 expression in osteoid osteomas. J. Orthop. Res. 20 (2002) 159-162
25. Naik A, Xie C, Zuscik M, Kingsley P, Schwarz E, Awad H, et al. Impaired Cox2/EP4 signaling leads to delayed fracture healing in aged mice. J. Bone Miner. Res.; in press.
26. O'Driscoll S.W., and Fitzsimmons J.S. The role of periosteum in cartilage repair. Clin. Orthop. Relat. Res. 391 Suppl (2001) S190-S207
27. O'Keefe R.J., Tiyapatanaputi P., Xie C., Li T.F., Clark C., Zuscik M.J., et al. COX-2 has a critical role during incorporation of structural bone allografts. Ann. N. Y. Acad. Sci. 1068 (2006) 532-542
28. Orwoll E.S. Toward an expanded understanding of the role of the periosteum in skeletal health. J. Bone Miner. Res. 18 (2003) 949-954
29. Shen W., Li Y., Zhu J., Schwendener R., and Huard J. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J. Cell Physiol. 214 (2008) 405-412
30. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17 (2002) 963-976
31. Simon A.M., and O'Connor J.P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J. Bone Joint Surg. Am. 89 (2007) 500-511
32. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Ann. Rev. Biochem. 69 (2000) 145-182
33. Tiyapatanaputi P., Rubery P.T., Carmouche J., Schwarz E.M., O'Keefe R.J., and Zhang X. A novel murine segmental femoral graft model. J. Orthop. Res. 22 (2004) 1254-1260
34. Wang D., Mann J.R., and DuBois R.N. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128 (2005) 1445-1461
35. Wlodarski K.H. Normal and heterotopic periosteum. Clin. Orthop. Relat. Res. 241 (1989) 265-277
36. Wu K.K. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostaglandins Leukot. Essent. Fatty Acids 72 (2005) 89-93
37. Zhang X., Morham S.G., Langenback R., Young D.A., Xing L., Boyce B.F., et al. Evidence for a direct role of COX-2 in implant wear debris induced osteolysis. J. Bon. Min. Res. 16 (2001) 660-669
38. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109 (2002) 1405-1415
39. Zhang X., Xie C., Lin A.S., Ito H., Awad H., Lieberman J.R., et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J. Bone Miner. Res. 20 (2005) 2124-2137